New hope for rare, aggressive lung cancer: experimental drug trial opens

This study is testing whether a new medicine called PF-08634404 works better when given with standard chemotherapy for a rare, aggressive form of lung cancer called transformed small cell lung cancer. The trial will enroll 40 adults who haven't received treatment for this specific cancer type yet. Researchers will give participants both the new medicine and chemotherapy, then continue with just the new medicine, monitoring how well the cancer responds and what side effects occur.